Phenotypic transcription factors epigenetically mediate cell growth control
Ribosomal RNA (rRNA) genes are down-regulated during osteogenesis, myogenesis, and adipogenesis, necessitating a mechanistic understanding of interrelationships between growth control and phenotype commitment. Here, we show that cell fate-determining factors [MyoD, myogenin (Mgn), Runx2, C/EBPβ] occ...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 105; no. 18; pp. 6632 - 6637 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
06-05-2008
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Ribosomal RNA (rRNA) genes are down-regulated during osteogenesis, myogenesis, and adipogenesis, necessitating a mechanistic understanding of interrelationships between growth control and phenotype commitment. Here, we show that cell fate-determining factors [MyoD, myogenin (Mgn), Runx2, C/EBPβ] occupy rDNA loci and suppress rRNA expression during lineage progression, concomitant with decreased rRNA expression and reciprocal loss of occupancy by c-Myc, a proliferation-specific activator of rRNA transcription. We find interaction of phenotypic factors with the polymerase I activator upstream binding factor UBF-1 at interphase nucleoli, and this interaction is epigenetically retained on mitotic chromosomes at nucleolar organizing regions. Ectopic expression and RNA interference establish that MyoD, Mgn, Runx2, and C/EBPβ each functionally suppress rRNA genes and global protein synthesis. We conclude that epigenetic control of ribosomal biogenesis by lineage-specific differentiation factors is a general developmental mechanism for coordinate control of cell growth and phenotype. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston, MA 02210-2206. Present address: Dana–Farber Cancer Institute, 44 Binney Street, Boston, MA 02115. Author contributions: S.A.A., S.K.Z., J.B.L., A.J.v.W., A.N.I., G.S.S., and J.L.S. designed research; S.A.A. and N.S. performed research; S.A.A., C.S.D., N.S., and A.N.I. contributed new reagents/analytic tools; S.A.A., S.K.Z., C.S.D., D.W.Y., M.A.M., J.B.L., A.J.v.W., A.N.I., G.S.S., and J.L.S. analyzed data; and S.A.A., S.K.Z., C.S.D., D.W.Y., A.R.S., M.A.M., J.B.L., A.J.v.W., A.N.I., G.S.S., and J.L.S. wrote the paper. Permanent address: School of Biological Sciences, University of the Punjab, Lahore 54590, Pakistan. Edited by Sheldon Penman, Massachusetts Institute of Technology, Cambridge, MA, and approved March 12, 2008 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0800970105 |